Gossamer Bio (GOSS)
NASDAQ:GOSS
Total Valuation
Gossamer Bio has a market cap or net worth of $86.84M. The enterprise value is $251.07M.
Market Cap$86.84M
Enterprise Value$251.07M
Share Statistics
Gossamer Bio has 234,696,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding234,696,270
Owned by Insiders3.94%
Owned by Institutions40.79%
Financial Efficiency
Gossamer Bio’s return on equity (ROE) is 1.39 and return on invested capital (ROIC) is -148.67%.
Return on Equity (ROE)1.39
Return on Assets (ROA)-0.99
Return on Invested Capital (ROIC)-148.67%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee336.60K
Profits Per Employee-1.18M
Employee Count144
Asset Turnover0.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Gossamer Bio is ―. Gossamer Bio’s PEG ratio is -0.02.
PE Ratio―
PS Ratio14.62
PB Ratio-5.77
Price to Fair Value-5.77
Price to FCF-4.13
Price to Operating Cash Flow-0.49
PEG Ratio-0.02
Income Statement
In the last 12 months, Gossamer Bio had revenue of 48.47M and earned -170.37M in profits. Earnings per share was -0.75.
Revenue48.47M
Gross Profit47.47M
Operating Income-163.25M
Pretax Income-170.46M
Net Income-170.37M
EBITDA-162.25M
Earnings Per Share (EPS)-0.75
Cash Flow
In the last 12 months, operating cash flow was -171.27M and capital expenditures -79.00K, giving a free cash flow of -171.34M billion.
Operating Cash Flow-171.27M
Free Cash Flow-171.34M
Free Cash Flow per Share-0.73
Dividends & Yields
Gossamer Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.40
52-Week Price Change-54.88%
50-Day Moving Average1.26
200-Day Moving Average2.16
Relative Strength Index (RSI)28.90
Average Volume (3m)26.89M
Important Dates
Gossamer Bio upcoming earnings date is May 12, 2026, After Close (Confirmed).
Last Earnings DateMar 17, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Gossamer Bio as a current ratio of 2.64, with Debt / Equity ratio of -164.52%
Current Ratio2.64
Quick Ratio2.64
Debt to Market Cap0.28
Net Debt to EBITDA-1.01
Interest Coverage Ratio-14.86
Taxes
In the past 12 months, Gossamer Bio has paid -88.00K in taxes.
Income Tax-88.00K
Effective Tax Rate<0.01
Enterprise Valuation
Gossamer Bio EV to EBITDA ratio is -5.38, with an EV/FCF ratio of -5.09.
EV to Sales18.00
EV to EBITDA-5.38
EV to Free Cash Flow-5.09
EV to Operating Cash Flow-5.10
Balance Sheet
Gossamer Bio has $136.93M in cash and marketable securities with $201.97M in debt, giving a net cash position of -$65.04M billion.
Cash & Marketable Securities$136.93M
Total Debt$201.97M
Net Cash-$65.04M
Net Cash Per Share-$0.28
Tangible Book Value Per Share-$0.54
Margins
Gross margin is 99.53%, with operating margin of -336.81%, and net profit margin of -351.49%.
Gross Margin99.53%
Operating Margin-336.81%
Pretax Margin-351.67%
Net Profit Margin-351.49%
EBITDA Margin-334.74%
EBIT Margin-336.81%
Analyst Forecast
The average price target for Gossamer Bio is $4.40, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$4.40
Price Target Upside1089.19% Upside
Analyst ConsensusHold
Analyst Count9
Revenue Growth Forecast-58.17%
EPS Growth Forecast-116.24%